Clinical Trial Update: Semaglutide PrIor to CathEeter Ablation in Patients With Atrial Fibrillation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the use of semaglutide before catheter ablation in patients with atrial fibrillation. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: University of Luebeck | Conditions: Atrial Fibrillation (AF) | Phase 4 | Status: NOT_YET_RECRUITING